美国总统特朗普：我们将降低药品价格。

Core Viewpoint - The U.S. President Trump announced plans to lower drug prices, indicating a significant policy shift aimed at making medications more affordable for consumers [1] Group 1: Policy Implications - The administration's focus on reducing drug prices may lead to changes in pricing strategies within the pharmaceutical industry [1] - Potential regulatory adjustments could impact how drug companies set prices and negotiate with insurers [1] Group 2: Market Reactions - Pharmaceutical companies may experience stock volatility as investors react to the announcement and its implications for future earnings [1] - The announcement could lead to increased scrutiny of drug pricing practices, affecting public perception and regulatory environment [1]